Anticoagulation strategies and long-term recurrence in patients with venous thromboembolism in the era of direct oral anticoagulants
Open Access
- 11 August 2023
- journal article
- research article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 118, 59-72
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (JP 21K16022)
This publication has 36 references indexed in Scilit:
- Incidence of venous thromboembolism in patients with cancer – A cohort study using linked United Kingdom databasesEuropean Journal of Cancer, 2013
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary EmbolismNew England Journal of Medicine, 2012
- Clinical Characteristics, Management, and Outcomes of Patients Diagnosed With Acute Pulmonary Embolism in the Emergency DepartmentJACC, 2011
- Oral Rivaroxaban for Symptomatic Venous ThromboembolismNew England Journal of Medicine, 2010
- Risk assessment for recurrent venous thrombosisThe Lancet, 2010
- Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reportingJournal of Thrombosis and Haemostasis, 2010
- Dabigatran versus Warfarin in the Treatment of Acute Venous ThromboembolismNew England Journal of Medicine, 2009
- The hemodynamics and diagnosis of venous diseaseJournal of Vascular Surgery, 2007
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patientsJournal of Thrombosis and Haemostasis, 2005
- Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosisBlood, 2002